Skip to main content
Press Release

Orlando Doctor Agrees To Pay $75,000 To Settle Controlled Substances Act Violations

For Immediate Release
U.S. Attorney's Office, Middle District of Florida

Orlando, FL – United States Attorney Maria Chapa Lopez announces today that Dr. Ajaz Afzal has agreed to pay the United States $75,000 to resolve allegations that he violated the Controlled Substances Act by improperly issuing prescriptions for schedule II drugs.

The settlement relates to Dr. Afzal’s issuance of prescriptions for schedule II drugs while he was out of the country. Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse. These drugs are also considered dangerous. According to the settlement agreement, from October 2013 through November 2015, Dr. Afzal issued 108 invalid prescriptions for schedule II drugs in violation of the Controlled Substances Act. 

“The United States Attorney’s Office uses every means necessary to prosecute doctors who violate the Controlled Substances Act,” said U.S. Attorney Maria Chapa Lopez. “This settlement highlights our commitment to hold accountable anyone who does not follow the law.”

This settlement resulted from a coordinated effort by the U.S. Attorney’s Office for the Middle District of Florida and the Drug Enforcement Administration. Assistant United States Attorney Jeremy R. Bloor led the investigation.

The settlement resolves the United States’ claims. The claims resolved by the settlement are allegations only, and there has been no determination of liability.

Updated December 4, 2018

Prescription Drugs